Kriptex Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Karad, Maharashtra, India, established in 2009.
2009 Karad, Maharashtra, India Struck Off
Last Updated:
About Kriptex Pharmaceuticals Private Limited

Kriptex Pharmaceuticals Private Limited, a struck off private limited company, was established on 17 November 2009 in Karad, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24230PN2009PTC134993. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Rupali Kiran Jadhav (Director), Kiran Suresh Jadhav (Managing Director). Past directors included Rajiv Tulshiram Ahire, Kiran Suresh Jadhav. It is based at 133, Mangalwar Peth, Karad Dist. Satara, Karad, Maharashtra, 415110.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230PN2009PTC134993

  • Registration Number

    134993

  • Incorporation Date

    17 November 2009

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 16 Year, 3 Months
Company report

Kriptex Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kriptex Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kriptex Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rupali Kiran Jadhav Director 12 May 2014 Current
Kiran Suresh Jadhav Managing Director 17 Nov 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 May 2014 Past
Pramod Abcsdd Director 17 Jan 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kriptex Pharmaceuticals.

Enhance accessibility to Kriptex Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Kriptex Pharmaceuticals revenue growth over time
Kriptex Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kriptex Pharmaceuticals?

Unlock access to Kriptex Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kriptex Pharmaceuticals?

Unlock and access historical data on people associated with Kriptex Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kriptex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kriptex Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kriptex Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Rupali Kiran Jadhav was appointed as a Director was appointed as a Director on 12 May 2014 & has been associated with this company since 11 years 9 months . was completed.

  • Director Appointment

    Progress on Kiran Suresh Jadhav was appointed as a Managing Director was appointed as a Managing Director on 17 Nov 2009 & has been associated with this company since 16 years 3 months . was documented.

  • Company Incorporation

    The activity Kriptex Pharmaceuticals Private Limited was registered on 17 Nov 2009 with Roc Pune & aged 16 years 3 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kriptex Pharmaceuticals Private Limited?

The CIN of Kriptex Pharmaceuticals Private Limited is U24230PN2009PTC134993.

Where is Kriptex Pharmaceuticals Private Limited headquartered?

Kriptex Pharmaceuticals Private Limited is headquartered at 133, Mangalwar Peth, Karad Dist. Satara, Karad, Maharashtra, 415110.

When was Kriptex Pharmaceuticals Private Limited incorporated?

Kriptex Pharmaceuticals Private Limited was incorporated on 17 November 2009.

Who are the current directors of Kriptex Pharmaceuticals Private Limited?

The current directors of Kriptex Pharmaceuticals Private Limited are

What is the primary industry of Kriptex Pharmaceuticals Private Limited?

The primary industry of Kriptex Pharmaceuticals Private Limited is Chemicals.

Is Kriptex Pharmaceuticals Private Limited a listed company?

Kriptex Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Kriptex Pharmaceuticals Private Limited?

The authorized capital of Kriptex Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available